Local News: Hiram, GA 

 | 

Sign Up

 | 

Sign In

Saturday Nov 7 | Posted by: roboblogger

Amgen Announces Overall Survival Results for Vectibix in First-Line Metastatic Colorectal Cancer

Full story: Drugs.com

Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix administered in combination with FOLFOX as a first-line treatment of metastatic colorectal cancer failed to meet a secondary endpoint of overall survival.

Leave a Comment

See all Biotech discussions »

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Daily Horoscope for November 27

Cancer

You may receive kudos from your superiors or important people in your community and the Moon blends with the Sun to encourage rewards from The Powers That Be. This has the potential to be a wonderful time for you. Look for growth-encouraging opportunities that will pay off in the new year.

Get your Horoscope »